… and both have proven successful. A synthetic GLP-1 was developed that is not broken down by the enzyme, for example: Byetta from Amylin ( AMLN ) or Victoza from Novo Nordisk ( NVO ). Inhibitors were also developed that Complete Story »
… has officially acquired Amylin Pharmaceuticals ( AMLN ) , while also preparing ..... following the completion of the Amylin deal. This may bring down ..... but also its acquisition of Amylin Pharmaceuticals is in a great position to …
… Spearheaded by the numerous bids put in to buy Amylin Pharmaceuticals , ultimately going to Bristol Meyers ..... Myers announced that it will acquire Amylin Pharmaceuticals for $5.3 billion. Amylin will provide drugs in the diabetes industry …
… reported second-quarter results, the highlights of which were the planned acquisition of biotech company Amylin Pharmaceuticals , Inc . ( AMLN ), as well as the presentation of clinical data on Bristol-Myers' pipeline of immuno-oncology drugs …
LONDON, Aug 9 (Reuters) - AstraZeneca has opted to pay a further $135 million to Bristol-Myers Squibb to get an equal say in decision-making regarding drugs developed by Amylin Pharmaceuticals , the diabetes specialist acquired jointly by the two partners.
Aug 9 (Reuters) - Eli Lilly and Co on Thursday raised its net profit forecast for 2012 to reflect income from the early payment of financial obligations from former partner Amylin Pharmaceuticals Inc , which has been acquired by Bristol-Myers Squibb Co.
… unsecured debt are expected to be used for general corporate purposes, including the pending acquisition of Amylin Pharmaceuticals Inc . ( Amylin ). See the full list of Bristol Myers Squibb's ratings at the end of this release. Fitch rece
… following stocks, despite significant market capitalizations, can exhibit high volatility as the example of Amylin Pharmaceuticals , Inc . ( AMLN ) had shown, which failed to reach such milestone (FDA approval). Investors who think about an investment …
… and albiglutide, a once-weekly GLP-1 peptide that could be a more convenient alternative to Novo Nordisk's NVO and Amylin 's AMLN competing diabetes products. The diabetes and cardiovascular markets are expansive, and darapladib and albiglutide could …
… purchased the diabetes drug maker Amylin Pharmaceuticals ( AMLN ) $5.3 billion . This is ..... Prior to this acquisition, Amylin was trading around $30.70 ..... for the financial status of Amylin . The price of the acquisition …